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ABSTRACT Glomerular basement membranes (GBM's) were subjected to digestion in situ with
glycosaminoglycan-degrading enzymes to assess the effect of removing glycosaminoglycans (GAG)
on the permeability of the GBM to native ferritin (NF) . Kidneys were digested by perfusion with
enzyme solutions followed by perfusion with NF. In controls treated with buffer alone, NF was seen
in high concentration in the capillary lumina, but the tracer did not penetrate to any extent beyond
the lamina rara interna (LRI) of the GBM, and little or no NF reached the urinary spaces. Findings in
kidneys perfused with Streptomyces hyaluronidase (removes hyaluronic acid) and chondroitinase-
ABC (removes hyaluronic acid, chondroitin 4- and 6-sulfates, and dermatan sulfate, but not heparan
sulfate) were the same as in controls. In kidneys digested with heparinase (which removes most GAG
including heparan sulfate), NF penetrated the GBM in large amounts and reached the urinary spaces.
Increased numbers of tracer molecules were found in the lamina densa (LD) and lamina rara externa
(LRE) of the GBM. In control kidneys perfused with cationized ferritin (CF), CF bound to heparan-
sulfate rich sites demonstrated previously in the laminae rarae; however, no CF binding was seen in
heparinase-digested GBM's, confirming that the sites had been removed by the enzyme treatment.
The results demonstrated that removal of heparan sulfate (but not other GAG) leads to a dramatic
increase in the permeability of the GBM to NF.
There is now widespread agreement that the glomerular base-
ment membrane (GBM) is the main filtration barrier serving
to retain plasma proteins in the circulation, and that it has both
size-selective and charge-selective properties (1, 3, 15, 16). Little
is known, however, about the role of GBM components in
establishing these properties. We have recently presented cy-
tochemical evidence (based on removal with specific enzymes)
demonstrating the presence of anionic sites consisting of gly-
cosaminoglycans (GAG) rich in heparan sulfate in the laminae
rarae (interna and externa) of the GBM (7). We have subse-
quently isolated GAG from purified GBM and have confirmed
by quantitative biochemical analysis the presence of GAG
(heparan sulfate and hyaluronic acid) in the GBM (8). Upon
fording the GAG, we speculated that these highly charged
polymers might play a role in establishing the permeability
properties of the GBM to plasma proteins. We here present
data that indicate the removal of GAG (heparan sulfate) from
the GBM leads to increased permeability of the GBM to native
ferritin (NF), thereby providing direct experimental support
for this suggestion.
MATERIALS AND METHODS
Materials
Male Charles River CD" rats weighing 100-150 g were used. Chondroitinase-
ABC (P. vulgaris) and Streptomyces hyaluronidase were purchased from Miles
Laboratories, Inc. (Elkhart, Ind.). Heparinase was prepared from F. heparinum
(11). Horse-spleen ferritin (two times crystallized, cadmium free) was obtained
from Calbiochem-Behring Corp., American Hoechst Corp. (San Diego, Calif.).
Cationized ferritin (CF) (pI = 7.3-7.5) was prepared as described previously (6).
Enzymes were tested and found to be active against the appropriate substrate
and to be free ofproteolytic activity as measured by the Azocoll assay (7, 14).
Enzyme Perfusion
Procedures for perfusion of the kidney with enzyme solutions were given
previously (7). Briefly, the kidneys were flushed with Krebs-Ringer's bicarbonate
(KRB) at 120-150 mm Hg for 1-2 min and then perfused with 4-5 ml of the_
enzyme solution. The vessels were clamped (to retain the enzyme), and the
kidneys were incubated for 30 minin a0.15 MNaCl bath as follows: heparinase,
l mg/ml in 0,05 M NaCl-acetate, pH 7.0, at 30°C; Streptomyces hyaluronidase,
50 U/ml in 0.02 MNaCl-acetate, pH 5.6, at 37°C; and chondroitinase-ABC, 2.5
U/ml in KRB, pH 7.6, at 37°C. Relatively high concentrations ofenzymes were
used to insure effective digestion of GAG. Control kidneys were perfused and
incubated with buffer alone.
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flushed with 5-7 ml of KRB for l-2 min followed by perfusion with NF (2.5-10
mg/ml), suspended either in freshly drawn, citrated rat arterial blood or in KRB,
containing 7.5% bovine serum albumin (BSA). Perfusion pressures (120-150 mm
Hg) and arterial flow rates (2.5-3.0 nil/min) were maintained constant. After
half ofthe perfusate (-10-15 ml) had been utilized, the kidney was fixed in situ
by subcapsular injection of Karnovsky's fixative (6% glutaraldehyde and 5%
paraformaldehyde in 0.15 M cacodylate buffer, pH 7.4) at the hilus while
simultaneously dripping fixative on the kidney surface. Subcapsular injection
and drip fixation were continued until the remaining perfusate had been con-
sumed. The renal artery and vein were then reclamped, the renal capsule was
removed, and the whole kidney was immersed in fixative for an additional hour.
Pieces ofkidney cortex were then prepared and processed for electron microscopy
(6). Experiments with different enzymes were performed in triplicate.
In a separate experiment, the kidney was digested with heparinase and then
perfused with CF (0.25 mg/ml) in KRB, pH 7.4, containing 7.5% BSA.
Ferritin Counts
For each experiment 12-15 normal sections through capillaries from at least
five to six different glomeruli were photographed and printed at 100,000. The
number of ferritin molecules present in the layers of the GBM (lamina rara
intema [LRI], lamina densa [LD], lamina rara externa [LRE]) were counted and
compared to the number in the capillary lumen. To obtain the latter, the region
adjacent to the endothelium and equivalent in width to that of the GBM was
counted. The ratio of the number of ferritin molecules present in each GBM
layer to that in the lumen was determined, multiplied by 100, and expressed as
the percent of the luminal concentration (Table I).
RESULTS
We have shown that heparan sulfate and small amounts of
hyaluronic acid are the only GAG detectable upon cellulose
acetate electrophoresis of GAG extracted from isolated GBM
(8). Ifother GAG are present, they must be present in relatively
small amounts. To assess the affect of removing each type of
GAG from the GBM, we employed three different enzymes
with different specificities: Streptomyces hyaluronidase which
digests only hyaluronic acid; chondroitinase-ABC which di-
gests hyaluronic acid; chondroitin 4- and 6-sulfates and der-
matan sulfate; and heparinase which digests all known GAG
except keratan sulfate (including heparan sulfate).
As reported previously (7), glomeruli from kidneys treated
TABLE I
Relative Distribution of Ferritin Particles in the Layers of the
GBM as Compared to the Capillary Lumen
Data are the means t SD.
* Data represent the results of counts on 12-15 sections from each of three
experiments. The average area counted was -0.3 pmt/section.
$ Expressed as the percent of the luminal concentration. The actual luminal
concentration of NF varied in different experiments from 400-1,300 mole-
cules/pmt .
with these enzymes or with the appropriate buffers alone
appeared quite intact with no recognizable structural altera-
tions (Figs. 2-5).
Distribution of NF in Buffer Controls
When control kidneys incubated with various buffers were
perfused with NF the findings were the same as obtained
previously in vivo (5) and in vitro(15) in that the NF molecules
did not penetrate to any great extent beyond the LRI, and little
or no NF reached the LRE or urinary spaces. NF was seen in
high concentration in the capillary lumen and in the endothe-
lial fenestrae and LRI (Fig. 1). Counts of ferritin molecules
revealed the existence of two concentration gradients: one
between the lumen and the LRI, and the other between the
LRI and the LD. As shown in Table I, the concentration of
NF in the LRI was 10-15% of the luminal concentration, and
the concentration in the LD was 3-4% of that in the lumen.
Results were the same whether NF was perfused in citrate or
in KRB-BSA.
Distribution of NF after Enzyme Perfusion
In kidneys digested with chondroitinase-ABC or hyaluroni-
dase, the ferritin concentration in each of the layers of the
GBM was similar or identical to that in the corresponding
buffer controls (Figs. 4 and 5; Table 1).
In kidneys digested with heparinase, however, there was a
dramatic increase in the permeability of the GBM to ferritin:
NF penetrated the GBM in large amounts, escaped into the
urinary spaces, and appeared in the tubule lumina. The amount
found in the urinary spaces varied from one capillary to
another, depending on the effectiveness ofthe fixation-gelation
ofthe contents of the urinary spaces, in some (^-15%) it reached
nearly 50% of the concentration in the capillary lumen (Fig. 2).
This is in striking contrast to the situation in buffer controls
(Fig. 1) and in kidneys digested with chondroitinase-ABC (Fig.
4) or hyaluronidase (Fig. 5) in which ferritin was seldom found
in the urinary spaces.
Increased amounts of NF were seen in all layers of the GBM
(Fig. 3) after heparinase treatment. Results of ferritin counts
indicated that the concentration of NF in the LRI was only
slightly increased (3-4%), whereas in the LD there was three
times and in the LRE there was >20 times the amount seen in
controls. Particularly notable was the fact that the concentra-
tion gradient between the LRI and the LD was greatly reduced
(Fig. 3).
Distribution of CF after Heparinase Digestion
We have previously shown (6) that CF with a pl of 7.3-7.5
is a useful cationic probe for labeling the heparan sulfate-rich
sites in the GBM in vivo because it binds to the GBM sitesbut
does not bind to the adjoining cell membranes. When CF was
perfused into the kidney in KRB containing 7.5% BSA the
findings were the same as those obtained previously when CF
was given intravenously: it bound to the anionic sites in the
LRI, LRE, and mesangial matrix where it was found in clusters
of 5-10 molecules distributed at regular (60 nm) intervals (Fig.
6). No binding to adjacent cell membranes was observed when
CF fractions with this pl range were used (6). However, in
kidneys digested with heparinase and perfused thereafter with
CF, the distribution of CF was radically changed; it was seen
distributed throughout the GBM (compare Figs. 6 and 7). The
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exp GBM layers Buffer controls
Acetate buffer, pH 7.0
Enzyme treatment
Heparinase
I LRI 15.6$ (1 .2.7) 19.3 (1 .4.6)
LD 3.9 (1 .1 .8) 11.4 (t3.6)
LRE 0.2 (t0.2) 4.4 (1 .1 .1)
Krebs buffer, pH 7.6 Chondroitinase-ABC
II LRI 10.3 (1 .2.1) 8.4 (t3.9)
LID 3.0 (1 .0.8) 2.4 (1 .1 .3)
LRE 0.1 (1 .0.2) 0.3 (1 .0.1)
Acetate buffer, pH 5.6 Streptomyces
hyaluronidase
III LRI 14.8 (1 .2.9) 15.3 (1 .5.0)
LD 3.9 (1 .0.9) 4.2 (1 .1 .6)
LRE 0.1 (1 .0.2) 0.1 (t0.1)FIGURE 1
￿
Portion of aglomerular capillary from a control kidney incubated with acetate buffer followed by perfusion with native
ferritin (10 mg/ml) suspended in KRB containing 7.5% BSA. Most of the ferritin molecules are restricted to the capillary lumen
(Cap) or the LRI of theGBM. Occasionally ferritin molecules are seen in the LD (arrow) or LRE of the basement membrane, but
none are present in the urinary spaces (US) . fp, foot processes; En, endothelium . x 100,000.
FIGURE 2
￿
Portion of a glomerular capillary from a kidney digested with heparinase followed by perfusion with NF containing
7.5% BSA. Numerous ferritin molecules have penetrated the GBM and are present in the urinary spaces (US) . More molecules are
seen (arrows) in the LD and in the LRE than in controls. Glomerular structure including that of the slit diaphragms (Sd ) is intact .
x 100,000 .
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rich anionic sites had been digested by the enzyme treatment .
DISCUSSION
In this investigation we have shown that removal of GAG
from the GBM by digestion with heparinase causes a dramatic
increase in the permeability of the GBM to NF . After hepari-
nase the tracer escaped into the urinary spaces in large amounts,
whereas no such leakage occurred under any of the other
conditions studied . Furthermore, our results indicate that the
permeability increase is specifically caused by removal of
heparan sulfate because no increase in the permeability of the
FIGUREs 3-5
￿
Portions of glomerular capillaries from kidneys digested with heparinase (Fig . 3), chondroitinase-ABC (Fig . 4), and
Streptomyces hyaluronidase (Fig . 5), followed by perfusion with NF suspended in KRB-BSA. After heparinase treatment increased
amounts of ferritin are seen in theGBM especially in the LD and LRE, whereas there is no change in the amount of NF found in
the GBM after treatment with the other two enzymes. US, urinary spaces; fp, foot processes ; En, endothelium ; Cap, capillary
lumen. x 100,000.
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￿
Section of a glomerular capillary from a kidney incubated with acetate buffer followed by perfusion with 0.25 mg/ml
CF (pl 7.3-7 .5) suspended in KRB-BSA . CF binds to heparan sulfate-rich anionic sites at regular (-60 nm) intervals located in the
LRI (j) and LRE (T) of the GBM . No binding to the adjacent cell membranes is observed . fp, foot processes ; US, urinary spaces; En,
endothelium ; Cap, capillary lumen . x 100,000 .
FIGURE 7
￿
Section of a glomerular capillary from a kidney digested with heparinase followed by perfusion with CF suspended in
KRB-BSA . CF is seen in high concentration in the LRI and distributed throughout the LD . The regular binding to the anionic sites
of the LRI or LRE is lost, indicating that the anionic sites have been effectively digested . x 100,000 .
GBM to ferritin was seen after removal of hyaluronic acid (by
treatment with Streptomyces hyaluronidase) or after digestion
with chondroitinase-ABC, an enzyme that removes most other
GAG (hyaluronic acid, chondroitins 4- and 6-sulfates, and
dermatan sulfate) but not heparan sulfate . This constitutes
direct evidence that the presence ofheparan sulfate is necessary
for maintaining the normal restrictive permeability properties
of the GBM to proteins the size of anionic ferritin (diameter
= 11 nm) and smaller.
We have previously shown (6) that the sulfated GAG (he-
paran sulfate) present in the GBM is concentrated in particles,
presumably as proteoglycans (protein-polysaccharide com-
plexes) which are distributed in a regular lattice-like network .
It cannot be determined whether the main effect of removing
heparan sulfate is on the charge-selective or the size-selective
properties of the GBM, or, in molecular terms, whether the
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increased permeability is caused by the removal of an electro-
static or a steric exclusion effect . However, because ofthe large
size of the ferritin and the amount ofleakage seen, an effect on
both seems likely .
The only GAG other than heparan sulfate detected so far in
the GBM in any significant quantity is hyaluronic acid . On the
basis ofthe studies of Laurent (10), removal of hyaluronic acid
might be expected to affect the permeability (diffusion) of the
GBM to proteins. However, removal of hyaluronic acid by
digestion with either Streptomyces hyaluronidase or chondroi-
tinase-ABC had no effect on the penetration ofNF into the
GBM . Of course this does not rule out an effect on its perme-
ability to molecules smaller in size than NF .'
' We have recently obtained autoradiographic evidence indicating that
removal of hyaluronic acid (by digestion with either hyaluronidase orIn the past it has been widely assumed that sialic acid present
on the surfaces of endothelial cellsand especially on epithelial
cells is responsible for the creation and maintenance of the
charge-barrier properties of the glomerulus(1, 9, 18). It should
be mentioned, however, that this assumption was not based on
direct evidence, but rather was based on (a) the fact that, at the
time, sialic acid was the only polyanion known to be present in
the glomerulus (13), and (b) the finding that sialoproteins are
reduced in glomeruli from animals with experimentally in-
duced glomerular diseases associated with proteinuria (12).
The accumulated evidence based on use of electron-dense
tracers (reviewed in references 3 and 4) indicates that the main
glomerular barrier to penetration of macromolecules lies at the
level of the LRI of the GBM because a variety of anionic and
neutral macromolecules (NF [5], albumin [16], IgG [171, and
dextrans [2]) fail to penetrate beyond this level. The present
studies indicate that there are two concentration gradients for
NF: one between the lumen and the LRI and the other between
the LRI and the LD. It is the latter that is eliminated or greatly
reduced afterremoval ofheparan sulfate, andas a consequence,
NF penetrates the LD and gains access to all the layers distal
to the LD. This constitutes direct evidence that heparan sulfate
is essential for maintenance of the normal glomerular perme-
ability barrier, and that maintenance of the heparan sulfate-
rich sites in the GBM are essential to the integrity of that
barrier.
In summary, we have demonstrated that heparan sulfate
plays a role in creating the normal restrictive permeability
properties of the GBM to macromolecules. Because, according
to our data (4, 6, 7), anionic sites similar to those in the GBM
are widely distributed in basement membranes, GAG can be
assumed to play a similar role in the permeability of other
basement membranes. Finally, the fact that GAG are essential
for normal filtration functions and their removal leads to
chondroitinase-ABC) leads to increased permeability of the GBM to
t25í-BSA. Leakage ofBSA into the urinary spaces of kidneys perfused
with heparinase was three timesand those perfused with S. hyaluron-
idase or chondroitinase ABC two times greater than that seen in
controls (Kanwar and Farquhar, 1980, Fed. Proc. 39:334).
protein leakage, raises the possibility that alterations in GAG
may play a role in the pathogenesis of diseases in which there
is proteinuria of glomerular origin.
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